Cardiac troponins and autoimmunity: Their role in the pathogenesis of myocarditis and of heart failure
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Despite the widespread use of cardiac troponins as biomarkers for the diagnosis and quantitation of cardiac injury, the effect of troponin release and a possible autoimmune response to the troponins is unknown. Other investigators reported that programmed cell death – 1 (PD-1) – receptor deficient mice developed severe cardiomyopathy with autoantibodies to troponin I. We found that immunization of genetically susceptible mice with troponin I but not troponin T induced a robust autoimmune response leading to marked inflammation and fibrosis in the myocardium. At later times, antibodies to cardiac myosin were detected in troponin – immunized mice. The severity of inflammation correlated with expression of chemokines RANTES, MIP-2, IP-10 and MCD-1 in the myocardium. Prior immunization with troponin I increased the severity of experimental infarctions, indicating that an autoimmune response to troponin I aggravates acute cardiac damage. Cardiac inflammation, fibrosis and functional impairment were transferred from immunized to naive recipients by CD4+ T cells, and the cytokine profile suggested both a Th2 and Th17 profile in A/J mice. Finally we identified an 18-mer of troponin I containing an immuno-dominant epitope.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · Circulation · doi:10.1161/01.cir.93.5.841 · Cited by 3,458 · cited 12×
“Cardiac Troponins and Autoimmune Cardiomyopathy 2.1 Animal studies Recently, Nishimura et al. [74] reported that PD-1 receptor deficient mice developed DCM with production of high-titered autoantibodies against a heart-specific, 30-kDa protein.”
BackgroundInfluentialAutoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Okazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M., Hiai, H., Matsumori, A., Minato, N., et al. (2003) · Nature Medicine · doi:10.1038/nm955 · Cited by 689 · cited 7×
“[12] purified this 30-kDa protein from heart extract and identified it as cardiac troponin I.”
BackgroundResultInfluentialFrom Infection to Autoimmunity
Fairweather, D., Kaya, Z., Shellam, G. R., Lawson, C. M., & Rose, N. R. (2001) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0492 · Cited by 328 · cited 1×
“Important roles have been shown for autoreactive T cells [52], cardiac-specific autoantibodies [53,57], various cytokines and chemokines [58-66], natural killer cells [67], and the complement system [68,69].”
BackgroundSelf-citationJahns, R., Boivin, V., Siegmund, C., Inselmann, G., Lohse, M. J., & Boege, F. (1999) · Circulation · doi:10.1161/01.cir.99.5.649 · Cited by 262
Fairweather, D., Yusung, S., Frisancho, S., Barrett, M., Gatewood, S., Steele, R., & Rose, N. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4731 · Cited by 229
Self-citationCardiac troponin I as diagnostic and prognostic marker in severe heart failure
La Vecchia, L., Mezzena, G., Zanolla, L., Paccanaro, M., Varotto, L., Bonanno, C., & Ometto, R. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00120-0 · Cited by 191
Contribution of the innate immune system to autoimmune myocarditis: a role for complement
Kaya, Z., Afanasyeva, M., Wang, Y., Dohmen, K. M., Schlichting, J., Tretter, T., Fairweather, D., Holers, V. M., & Rose, N. R. (2001) · Nature Immunology · doi:10.1038/90686 · Cited by 175
Self-citationEriksson, U., Kurrer, M. O., Sonderegger, I., Iezzi, G., Tafuri, A., Hunziker, L., Suzuki, S., Bachmaier, K., Bingisser, R. M., Penninger, J. M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021788 · Cited by 158 · cited 1×
“Important roles have been shown for autoreactive T cells [52], cardiac-specific autoantibodies [53,57], various cytokines and chemokines [58-66], natural killer cells [67], and the complement system [68,69].”
BackgroundAntibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity.
Liao, L., Sindhwani, R., Rojkind, M., Factor, S., Leinwand, L., & Diamond, B. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1123 · Cited by 155 · cited 2×
“Important roles have been shown for autoreactive T cells [52], cardiac-specific autoantibodies [53,57], various cytokines and chemokines [58-66], natural killer cells [67], and the complement system [68,69].”
BackgroundEriksson, U., Kurrer, M. O., Schmitz, N., Marsch, S. C., Fontana, A., Eugster, H.-P., & Kopf, M. (2003) · Circulation · doi:10.1161/01.cir.0000043802.38699.66 · Cited by 150
Fairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Steele, R. A., Gatewood, S. J. L., & Rose, N. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.261 · Cited by 133
Self-citationQuantitative Analysis of Myocardial Inflammation by Flow Cytometry in Murine Autoimmune Myocarditis
Afanasyeva, M., Georgakopoulos, D., Belardi, D. F., Ramsundar, A. C., Barin, J. G., Kass, D. A., & Rose, N. R. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63169-0 · Cited by 124
Self-citationAfanasyeva, M., Georgakopoulos, D., Belardi, D. F., Bedja, D., Fairweather, D., Wang, Y., Kaya, Z., Gabrielson, K. L., Rodriguez, E. R., Caturegli, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408241102 · Cited by 89
Self-citationFairweather, D., Frisancho-Kiss, S., Njoku, D. B., Nyland, J. F., Kaya, Z., Yusung, S. A., Davis, S. E., Frisancho, J. A., Barrett, M. A., & Rose, N. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3516 · Cited by 82
Self-citationAutoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy
Shmilovich, H., Danon, A., Binah, O., Roth, A., Chen, G., Wexler, D., Keren, G., & George, J. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.04.077 · Cited by 66
Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy.
Goldman, J. H., Keeling, P. J., Warraich, R. S., Baig, M. K., Redwood, S. R., Dalla Libera, L., Sanderson, J. E., Caforio, A. L., & McKenna, W. J. (1995) · Heart · doi:10.1136/hrt.74.6.598 · Cited by 62
Cited by
Hofmann, U., Beyersdorf, N., Weirather, J., Podolskaya, A., Bauersachs, J., Ertl, G., Kerkau, T., & Frantz, S. (2012) · Circulation · doi:10.1161/circulationaha.111.044164 · Cited by 471
Blauwet, L. A., & Cooper, L. T. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.11.006 · Cited by 374
The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy
Heymans, S., Eriksson, U., Lehtonen, J., & Cooper, L. T. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.937 · Cited by 359
Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration
Li, J., Tan, J., Martino, M. M., & Lui, K. O. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00585 · Cited by 344
Structural insight into the unique properties of adeno-associated virus serotype 9
DiMattia, M. A., Nam, H.-J., Van Vliet, K., Mitchell, M., Bennett, A., Gurda, B. L., McKenna, R., Olson, N. H., Sinkovits, R. S., Potter, M., et al. (2012) · Journal of Virology · doi:10.1128/jvi.07232-11 · Cited by 219
Metadata
- Authors
- Kaya, Z., Katus, H. A., & Rose, N. R.
- Venue
- Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 134
- Issue
- 1
- Pages
- 80-88
- ISSN
- 1521-6616 (ISSN-L)
- OpenAlex
- W2039229911
- Cited by
- 98
- References
- 17
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.